Authors
Loading...
Expert review demonstrates the therapeutic and disease-modeling potential of induced pluripotent stem cell-derived cardiomyocytes, highlighting their role in advancing personalized cardiac medicine.
Karakikes et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: